Alyssa L Dantonio (Alyssa Dantonio)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Replacement Therapy

Induced Pluripotent Stem Cells

Respiratory Syndrome Coronavirus

High Throughput

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Xenobiotica; the fate of foreign compounds in biological systems

This page only lists publications with an associated author ORCID identifier.

Publications

Siennah R Greenfield, Heather Eng, Qingyi Yang, Chunyang Guo, Laura J Byrnes, Alyssa L Dantonio, Graham M West, Li Di, Amit S Kalgutkar
Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir. Xenobiotica; the fate of foreign compounds in biological systems (2023)
Heather Eng, Alyssa L Dantonio, Eugene P Kadar, R Scott Obach, Li Di, Jian Lin, Nandini C Patel, Britton Boras, Gregory S Walker, Jonathan J Novak, Emi Kimito, Ravi Shankar Prasad Singh, Amit S Kalgutkar
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans. Drug metabolism and disposition: the biological fate of chemicals 50 (5) (2022)